MedPath

Investigation of Low-intensity Focused Ultrasound for Human Pain Management

Not Applicable
Conditions
Chronic Pain
Interventions
Device: Low Intensity Focused Ultrasound
Registration Number
NCT05145426
Lead Sponsor
Virginia Polytechnic Institute and State University
Brief Summary

This project examines the effects of noninvasive brain stimulation on pain. The investigators believe this study will help to better understand possible treatments for chronic pain patients. Participants undergo structural imaging, a functional Magnetic Resonance Image (fMRI) and computed tomography (CT). These images are used to align the low-intensity focused ultrasound (LIFU) device which uses sound waves to temporarily change brain activity. Pain testing is done using a small device that will increase/decrease the temperature of the skin. Brain signals are collected using electroencephalography (EEG). Heart rate, blood pressure, and skin moisture will be monitored as well.

Detailed Description

Not available

Recruitment & Eligibility

Status
ENROLLING_BY_INVITATION
Sex
All
Target Recruitment
80
Inclusion Criteria
  • Understand and speak English
Read More
Exclusion Criteria
  • MRI/CT/EEG contraindications.

    1. Claustrophobia
    2. Contraindications to MRI: including pacemaker, aneurysm clips, neurostimulators, cochlear implants, metal in eyes, steel worker, or other implants.
    3. Contraindications to CT: pregnancy
    4. Active medical disorder or treatment with potential CNS effects
    5. History of neurologic disorder
    6. History of head injury resulting in loss of consciousness for >10 minutes.
    7. History of alcohol or drug dependence
    8. Failure to provide Social Security Number or Tax ID number. This is required for tax purposes or payment cannot be processed.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Pain TrialsLow Intensity Focused UltrasoundMulti visit - LIFU/Sham application, with quantitative sensory testing (using peltier device).
Primary Outcome Measures
NameTimeMethod
Perceived sensation scoreAssessed per participant, over the course of participation - an average of 3 weeks.

Changed perceived sensation score on a 1-10 scale in response to painful stimuli.

Secondary Outcome Measures
NameTimeMethod
Windup PainAssessed per participant, over the course of participation - an average of 3 weeks

Changed windup pain score on a 1-10 scale.

CHEP AmplitudeAssessed per participant, over the course of participation - an average of 3 weeks

Attenuated N1/P1 CHEP amplitude recorded with EEG

Trial Locations

Locations (1)

Fralin Biomedical Research Institute

🇺🇸

Roanoke, Virginia, United States

© Copyright 2025. All Rights Reserved by MedPath